Barbara Seroczynska
Overview
Explore the profile of Barbara Seroczynska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesicka M, Jablonska E, Wieczorek E, Peplonska B, Gromadzinska J, Seroczynska B, et al.
Int J Mol Sci
. 2019 Nov;
20(22).
PMID: 31739444
Breast cancer (BC) is a major problem for civilization, manifested by continuously increasing morbidity and mortality among women worldwide. Core circadian genes may play an important role in cancer development...
2.
Lesicka M, Jablonska E, Wieczorek E, Seroczynska B, Kalinowski L, Skokowski J, et al.
Chronobiol Int
. 2019 Jun;
36(8):1103-1114.
PMID: 31179760
One of the supposed mechanisms that may lead to breast cancer (BC) is an alteration of circadian gene expression and DNA methylation. We undertook an integrated approach to identify methylation...
3.
Markiewicz A, Topa J, Nagel A, Skokowski J, Seroczynska B, Stokowy T, et al.
Cancers (Basel)
. 2019 Jan;
11(1).
PMID: 30634453
Circulating tumour cells (CTCs) can provide valuable prognostic information in a number of epithelial cancers. However, their detection is hampered due to their molecular heterogeneity, which can be induced by...
4.
Altered circadian genes expression in breast cancer tissue according to the clinical characteristics
Lesicka M, Jablonska E, Wieczorek E, Seroczynska B, Siekierzycka A, Skokowski J, et al.
PLoS One
. 2018 Jun;
13(6):e0199622.
PMID: 29958276
Breast cancer has a multifactorial etiology. One of the supposed and novel mechanisms is an alteration of circadian gene expression. Circadian genes play a crucial role in many physiological processes....
5.
Gojska-Grymajlo A, Zielinski M, Gasecki D, Kowalczyk K, Kwarciany M, Seroczynska B, et al.
Neuromolecular Med
. 2018 May;
20(3):301-311.
PMID: 29744773
Ischemic stroke causes mobilization of various groups of progenitor cells from bone marrow to bloodstream and this correlates with the neurological status of stroke patients. The goal of our study...
6.
Markiewicz A, Nagel A, Szade J, Majewska H, Skokowski J, Seroczynska B, et al.
Transl Oncol
. 2018 Apr;
11(3):722-731.
PMID: 29660692
Intratumoral heterogeneity of breast cancer remains a major challenge in successful treatment. Failure of cancer therapies can also be accredited to inability to systemically eradicate cancer stem cells (CSCs). Recent...
7.
Czapiewski P, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Sejda A, Szade J, et al.
Pol J Pathol
. 2015 Dec;
66(3):269-75.
PMID: 26619106
CD99 is a protein initially described in the Ewing sarcoma family of tumors, but growing evidence has shown its expression in other tumors of mesenchymal, hematopoietic and even epithelial origin....
8.
Differentiation of high-risk stage I and II colon tumors based on evaluation of CAV1 gene expression
Kitowska A, Wesserling M, Seroczynska B, Szutowicz A, Ronowska A, Peksa R, et al.
J Surg Oncol
. 2015 Aug;
112(4):408-14.
PMID: 26251082
Background: Several molecular markers are currently being investigated for their prognostic or predictive value in colorectal cancer. One of the genes proposed, as a potential molecular marker in CRC is...
9.
Ronowicz A, Janaszak-Jasiecka A, Skokowski J, Madanecki P, Bartoszewski R, Balut M, et al.
Hum Mutat
. 2015 Jul;
36(11):1088-99.
PMID: 26219265
Somatic mosaicism for DNA copy-number alterations (SMC-CNAs) is defined as gain or loss of chromosomal segments in somatic cells within a single organism. As cells harboring SMC-CNAs can undergo clonal...
10.
Markiewicz A, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Majewska H, Szade J, et al.
Am J Transl Res
. 2015 Jan;
6(6):793-808.
PMID: 25628790
Epithelial-mesenchymal transition (EMT) was shown to enhance metastatic abilities of cancer cells, but it remains elusive in clinical samples. Moreover, EMT is rarely studied in lymph node metastases (LNM), thus...